What Is Longevity Medicine? A Patient Guide to Healthspan, Testing, and Treatments

Longevity medicine is a preventive, personalized approach to healthcare focused on extending healthspan—the years lived in good health—rather than simply promising a longer life. It combines risk screening, lifestyle medicine, validated monitoring, and, in some cases, clinician-guided treatments. Evidence is strongest for prevention and lifestyle; many drug, peptide, and biomarker claims remain early or experimental 1.

What is longevity medicine?

Longevity medicine is care that tries to find risk earlier, reduce chronic disease burden, and preserve function over time. A major review describes it as an emerging discipline built around early detection, prevention, lifestyle, and personalized care 1.

Healthspan vs lifespan

Lifespan is how long a person lives. Healthspan is how long a person lives with good function, fewer disabling symptoms, and lower disease burden. In practical care, healthspan is the more useful target because it can be tracked with risk factors, labs, strength, sleep, symptoms, and disease screening 1.

How longevity medicine differs from traditional reactive care

Traditional care often starts when symptoms appear. Longevity care tries to act earlier. That may mean checking blood pressure, glucose, cholesterol, body composition, family history, sleep, strength, and cancer-screening status before a serious event happens 1.

Why prevention, early detection, and personalization are central

The most grounded version of longevity medicine is not a single pill or peptide. It is a system: identify risk, address the biggest modifiable factors, monitor over time, and adjust the plan as a person’s health changes 1.

What should patients know before trying longevity medicine?

Longevity medicine is broad, so the first question is not “What should I take?” It is “What problem are we trying to reduce, and what evidence supports this plan?” A responsible plan separates proven prevention from promising but unproven interventions.

• Proven basics matter first: blood pressure control, lipid management when appropriate, diabetes risk reduction, exercise, nutrition, sleep, vaccines, and evidence-based cancer screening are core prevention tools 1.
• Biomarkers are not destiny: DNA methylation clocks and other biomarkers of aging may help research, but they need validation before they can stand in for clinical outcomes 2.
• Human lifespan trials are difficult: studies that wait for people to live longer can require large groups and long follow-up, so many trials use intermediate outcomes instead 3.
• Experimental does not mean useless: it means the evidence is still developing, and the risks, benefits, dose, route, and right patient group are not fully settled 2.
• Clinician oversight matters: medications and peptides can have side effects, contraindications, and drug interactions, especially when combined with other therapies.

What is proven, what is promising, and what is experimental

Is longevity medicine the same as anti-aging?

Longevity medicine is not the same as anti-aging marketing. The phrase anti-aging often suggests that aging can be stopped or reversed. Evidence-based longevity care is more careful: it focuses on lowering risk, preserving function, and measuring health over time 1.

Why the term anti-aging can be misleading

Aging is complex. It involves inflammation, cellular senescence, mitochondrial dysfunction, DNA damage, hormonal changes, and chronic disease risk. Geroscience studies these pathways because they may contribute to multiple age-related diseases, but that does not mean any one intervention has proven it can extend human lifespan 2.

How evidence-based longevity care focuses on risk reduction and healthy aging

A good longevity plan should sound more like careful medicine than a promise. It should connect each test or treatment to a real goal: lower cardiometabolic risk, preserve muscle, improve sleep, monitor safety, or detect disease earlier 1.

What does a responsible longevity medicine plan usually include?

A responsible plan starts with 1 clear medical review, not a shopping list of supplements. It usually includes history, medications, family risk, basic labs, lifestyle review, and follow-up testing when needed 1.

Medical history and risk review

A clinician should review medical conditions, medications, allergies, pregnancy status when relevant, family history, sleep, nutrition, activity, alcohol, nicotine, and prior lab results. This matters because a treatment that is reasonable for one person may be unsafe or unnecessary for another.

Basic labs and cardiometabolic risk screening

Common targets include blood pressure, lipids, glucose control, kidney and liver markers, weight history, waist circumference, and other tests based on risk. These are not glamorous, but cardiometabolic disease is a major driver of disability and early death, so risk reduction is central to healthspan care 1.

Nutrition, exercise, sleep, and strength preservation

Exercise and nutrition are not “basic” because they are weak. They are basic because they sit underneath almost every other longevity goal: insulin sensitivity, blood pressure, muscle, balance, sleep quality, and independence. Caloric restriction studies in humans have shown changes in cardiometabolic and aging-related biomarkers, but those biomarker changes should not be described as proven human lifespan extension 9.

Longitudinal monitoring instead of one-time snapshots

Repeated testing can be more useful than a single test because it shows direction. Longitudinal testing in clinical research helps track safety, biological response, and trends over time rather than one isolated value 4.

What does the science say about longevity medications?

Geroscience asks whether targeting aging biology could reduce several age-related diseases at once. That is a serious research question, but it still requires the same careful steps as drug development: define the population, dose, safety plan, outcome, and regulatory path 2.

Geroscience and the idea of targeting aging mechanisms

Researchers study pathways such as mTOR signaling, sirtuins, senescent-cell biology, mitochondrial function, chronic inflammation, and caloric restriction biology. Animal and cell studies have produced important leads, but strong preclinical results do not automatically translate into proven human benefit 3.

Why human lifespan trials are hard to run

A trial designed to prove that a medication makes humans live longer could take decades. That is why studies often use intermediate outcomes, such as disease events, function, biomarkers, or safety signals. The FDA and NIA note that geroscience programs still need clear clinical context and meaningful endpoints 2.

Why biomarkers are useful but not the same as proven clinical outcomes

A biomarker can show exposure, risk, or biological response. But before a biomarker can replace a clinical outcome, it must be validated for that exact use. DNA methylation clocks, for example, are important research tools, but a lower clock result should not be treated as proof that a person will live longer 2, 10.

Examples often discussed in research

Metformin, rapamycin, GLP-1 medicines, NAD+, peptides, and senolytic strategies are often discussed in longevity circles. The evidence is not equal across them. Some have strong human data for specific diseases or labeled uses; others are mainly animal, cell, biomarker, or early human evidence 2, 3.

For example, semaglutide, sold under brand names Ozempic and Wegovy, is a GLP-1 receptor agonist. The FDA-approved Wegovy label includes a starting dose of 0.25 mg once weekly with titration to maintenance dosing for chronic weight management and cardiovascular risk reduction in specific adults 5. Tirzepatide, sold under brand names Mounjaro and Zepbound, is a dual GIP/GLP-1 receptor agonist; the FDA-approved Zepbound label includes once-weekly dosing for chronic weight management in specific adults 6. These label-based facts do not establish outcomes for compounded formulations.

GLP-1 and GIP/GLP-1 medicines can cause nausea, vomiting, diarrhea, constipation, abdominal pain, and other adverse effects. Labels also include warnings and contraindications, including thyroid C-cell tumor risk language and contraindication in people with a personal or family history of medullary thyroid carcinoma or MEN2 for Wegovy and Zepbound 5, 6.

How strong is the evidence for common longevity interventions?

The honest answer is: it depends on the intervention and the outcome. Human clinical evidence is strongest when a therapy has been tested in controlled trials for a defined condition; animal and cell findings are useful but much earlier.

How to read biomarker claims without overinterpreting them

Ask what the biomarker is measuring, whether it has been validated for that use, and whether a change in the marker predicts a real clinical outcome. The FDA’s geroscience discussion stresses context of use, proof of concept, safety, and clinically meaningful outcomes 2.

Longevity medicine at Chia: clinician-guided peptides and metabolic health support

At Chia, we offer a clinician-reviewed path for eligible patients who want longevity and metabolic health support. We do not claim that any treatment extends human lifespan. Our role is to evaluate health goals, review safety, and prescribe only when clinically appropriate.

Chia offers NAD+ as injection or nasal spray, glutathione as injection or nasal spray, sermorelin as injection, nasal spray, or tablets, and GHK-Cu cream as a topical cream. We also offer low-dose naltrexone tablets, semaglutide injection, and tirzepatide tablets or injection for eligible patients through licensed-provider review.

Sermorelin acetate, formerly marketed as Geref, is a growth hormone-releasing hormone analog. The historical Geref label described it for evaluating growth hormone secretion in children, with adverse reactions including injection-site reactions, flushing, headache, nausea, and dizziness 7. Use in longevity care should not be framed as proven lifespan extension.

Bremelanotide, brand name Vyleesi, is a melanocortin receptor agonist peptide related to PT-141. The FDA-approved Vyleesi label is for acquired, generalized hypoactive sexual desire disorder in premenopausal women and includes warnings such as transient blood pressure increases and nausea 8. Chia offers PT-141 nasal spray, which is compounded and not FDA-approved.

Treatment at Chia is 100% online. Patients complete a health questionnaire, then a licensed US provider reviews it. If prescribed, medication is compounded in the US by state-licensed 503A pharmacies and shipped to the patient’s door. Dosing is provider-guided and adjusted over time, and patients can message the care team through the patient portal.

What are longevity peptides?

Longevity peptides are short chains of amino acids that can signal specific biological pathways. They are different from vitamins and supplements because many act more like targeted signaling molecules, and their effects can vary by dose, route, and patient group 7, 8.

How peptides are different from vitamins and supplements

A vitamin usually replaces or supports a nutrient need. A peptide may bind to a receptor or influence a signaling pathway. That is why peptide care should be clinician-guided, especially when injections, nasal sprays, or combinations are involved 7, 8.

Sermorelin, GHK-Cu, and PT-141: different mechanisms and use cases

Sermorelin is a growth hormone-releasing hormone analog, so its clinical logic is tied to the growth hormone axis rather than general “anti-aging” 7. GHK-Cu is a copper peptide used in skin-focused products, including Chia’s compounded GHK-Cu cream. PT-141 is related to bremelanotide, a melanocortin receptor agonist with an FDA-approved sexual-health indication for a specific population under the Vyleesi label 8.

Why peptide evidence varies

Peptide evidence varies by molecule, route, dose studied, formulation, and population. A peptide studied for one purpose cannot automatically be assumed to work for another purpose. Side effects can also differ by route; for example, labels for injectable peptide drugs may include blood pressure effects, nausea, flushing, or injection-site reactions depending on the molecule 7, 8.

What is the best longevity supplement?

There is no single best longevity supplement for everyone. The best next step depends on the person’s risks, diet, medications, lab results, sleep, training, and goals.

For many people, the highest-yield “longevity” move is not adding another capsule. It may be treating high blood pressure, improving lipids, building muscle, improving sleep apnea, reducing alcohol, stopping nicotine, or addressing prediabetes. These targets are more directly tied to healthspan than most supplement claims 1.

Lab testing can help when there is a real clinical question, such as deficiency risk, metabolic risk, kidney or liver safety, or medication interaction. Testing is less useful when it creates a long list of abnormal-looking markers with no validated action plan.

How should patients choose a longevity clinic or telehealth provider?

Choose a provider who can explain evidence, safety, and uncertainty in plain language. Licensed clinician review and clear follow-up matter more than a long menu of tests.

• Look for licensed clinician review before any prescription treatment.
• Ask what evidence supports each recommendation: human clinical, human observational, animal, or cell-based.
• Ask what side effects, contraindications, and interactions matter for you.
• Confirm whether a treatment is FDA-approved for the use being discussed or compounded through a state-licensed 503A pharmacy.
• Avoid clinics that promise lifespan extension, guaranteed age reversal, or certain biomarker changes.
• Make sure there is a follow-up plan, not just a one-time purchase.

At Chia, our process is built around online evaluation, licensed-provider review, provider-guided dosing, state-licensed 503A pharmacy compounding, home delivery, and portal messaging. For patients interested in metabolic protocols, we offer Weight + Energy and Weight + Muscle for eligible patients using GLP-1-based care.

FAQ

Keep reading

Peptides

What Are Peptides Used For? Medical Uses, Wellness Claims, and Safety

Peptides

Where to Get Peptide Injections Safely: Prescriptions, Telehealth, and What to Avoid

Peptides

Peptide Injections: What They Are, How They Work, and What to Expect